A Stable Clinical Trial Study Team with Trial Legacy Capability Makes All the Difference
The smaller, niche CRO that is well managed, with stable clinical trial study teams that provide trial legacy capability, and…
The smaller, niche CRO that is well managed, with stable clinical trial study teams that provide trial legacy capability, and…
Valuable activities SMOs and CROs can provide sponsors are identification, activation, and engagement. Ideally, study sponsors can gain: rapid patient…
Scimega Research, Canada’s premier oncology contract research organization (CRO), was founded twenty-five years ago by two dynamic entrepreneurs, Denise Deakin…
Canada’s world-class researchers and diverse patient population make it one of the top 6 countries in the world for enrollment of…
The TMF is the official record of the clinical study for Regulatory Authorities, be it the FDA, Health Canada, or…
Partnerships sometimes do not work out as intended. For medium size and smaller biotech companies enlisting the services of a…
It’s worth your time to consider whether or not the commonly held belief that using a larger CRO for your…
The Global Clinical Trials Market was valued at $44.3B USD in 2020, and by 2028 is expected to reach $69.3B…
Pre-pandemic oncology was both the largest and fastest growing therapeutic area in the clinical trials market. A key market trend…
Participant diversity in clinical trials can be quite challenging to achieve. With COVID the concern about appropriate demographic representation is…